BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27318443)

  • 1. Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma.
    Racher H; Soliman S; Argiropoulos B; Chan HS; Gallie BL; Perrier R; Matevski D; Rushlow D; Piovesan B; Shaikh F; MacDonald H; Corson TW
    Cancer Genet; 2016; 209(7-8):359-63. PubMed ID: 27318443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
    Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P
    Mol Vis; 2021; 27():1-16. PubMed ID: 33456302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of germline
    Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
    Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
    Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
    Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and reporting of RB1 promoter hypermethylation in diagnostic screening.
    Price EA; Kolkiewicz K; Patel R; Hashim S; Karaa E; Scheimberg I; Sagoo MS; Reddy MA; Onadim Z
    Ophthalmic Genet; 2018 Aug; 39(4):526-531. PubMed ID: 29851531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of mutations in the
    Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
    Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular alterations in retinoblastoma beyond RB1.
    Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
    Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Fang X; Chen J; Wang Y; Zhao M; Zhang X; Yang L; Ni X; Zhao J; Gallie BL
    Ophthalmic Genet; 2021 Oct; 42(5):593-599. PubMed ID: 34190019
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutational screening of germline
    Nguyen HH; Nguyen HTT; Vu NP; Le QT; Pham CM; Huyen TT; Manh H; Pham HLB; Nguyen TD; Le HTT; Van Nong H
    Mol Vis; 2018; 24():231-238. PubMed ID: 29568217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
    Berry JL; Lewis L; Zolfaghari E; Green S; Le BHA; Lee TC; Murphree AL; Kim JW; Jubran R
    Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867
    [No Abstract]   [Full Text] [Related]  

  • 11. Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort.
    Singh J; Mishra A; Pandian AJ; Mallipatna AC; Khetan V; Sripriya S; Kapoor S; Agarwal S; Sankaran S; Katragadda S; Veeramachaneni V; Hariharan R; Subramanian K; Mannan AU
    Mol Vis; 2016; 22():1036-47. PubMed ID: 27582626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-grade glioma: A rare second tumor in retinoblastoma survivors.
    Dalvi N; Kleinerman RA; Epelman S; Abramson DH; Dunkel IJ
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28770. PubMed ID: 33063942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
    Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
    Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danish retinoblastoma patients 1943-2013 - genetic testing and clinical implications.
    Gregersen PA; Urbak SF; Funding M; Overgaard J; Jensen UB; Alsner J
    Acta Oncol; 2016; 55(4):412-7. PubMed ID: 26494512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Retinoblastoma.
    Mallipatna A; Marino M; Singh AD
    Asia Pac J Ophthalmol (Phila); 2016; 5(4):260-4. PubMed ID: 27488068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous identification of clinically relevant
    Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
    Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome.
    Mehyar M; Mosallam M; Tbakhi A; Saab A; Sultan I; Deebajah R; Jaradat I; AlJabari R; Mohammad M; AlNawaiseh I; Al-Hussaini M; Yousef YA
    Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):152-159. PubMed ID: 32222358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
    Dimaras H; Rushlow D; Halliday W; Doyle JJ; Babyn P; Abella EM; Williams J; Héon E; Gallie BL; Chan HS
    Transl Res; 2010 Aug; 156(2):91-7. PubMed ID: 20627193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic intracranial retinoblastoma in a 3.5-month-old infant without eye involvement and without evidence of heritability.
    Römer T; Temming P; Lohmann DR; Sturm D; von Deimling A; Sellhaus B; Mull M; Kontny U; Moser O
    Pediatr Blood Cancer; 2019 May; 66(5):e27599. PubMed ID: 30604586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel deep intronic low penetrance RB1 variant in a retinoblastoma family.
    Soliman SE; Racher H; Lambourne M; Matevski D; MacDonald H; Gallie B
    Ophthalmic Genet; 2018 Apr; 39(2):288-290. PubMed ID: 29099630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.